2. International Diabetes Federation. IDF diabetes atlas. 8th ed. Brussels: International Diabetes Federation; 2017.
3. Yeung RO, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon KH, et al. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol 2014;2:935-943.
4. Peters A, Laffel L. American Diabetes Association Transitions Working Group. Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems. A position statement of the American Diabetes Association, with representation by the American College of Osteopathic Family Physicians, the American Academy of Pediatrics, the American Association of Clinical Endocrinologists, the American Osteopathic Association, the Centers for Disease Control and Prevention, Children with Diabetes, The Endocrine Society, the International Society for Pediatric and Adolescent Diabetes, Juvenile Diabetes Research Foundation International, the National Diabetes Education Program, and the Pediatric Endocrine Society (formerly Lawson Wilkins Pediatric Endocrine Society). Diabetes Care 2011;34:2477-2485.
5. Daneman D, Nakhla M. Moving on: transition of teens with type 1 diabetes to adult care. Diabetes Spectr 2011;24:14-18.
6. Adams JD, Hayes J, Hopson B. Transition: understanding and managing personal change. London: Martin Robertson; 1976.
7. Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA, et al. T1D Exchange Clinic Network. Current state of type 1 diabetes treatment in the US: updated data from the T1D Exchange clinic registry. Diabetes Care 2015;38:971-978.
8. McKnight JA, Wild SH, Lamb MJ, Cooper MN, Jones TW, Davis EA, et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med 2015;32:1036-1050.
10. DiMeglio LA, Acerini CL, Codner E, Craig ME, Hofer SE, Pillay K, et al. ISPAD Clinical Practice Consensus Guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes 2018;19 Suppl 27:105-114.
11. American Diabetes Association. 13. Children and adolescents: standards of medical care in diabetes. 2019. Diabetes Care 2019;42 Suppl 1:S148-S164.
12. Lewis K, Hermayer K. All grown up: moving from pediatric to adult diabetes care. Am J Med Sci 2013;345:278-283.
14. Hislop AL, Fegan PG, Schlaeppi MJ, Duck M, Yeap BB. Prevalence and associations of psychological distress in young adults with type 1 diabetes. Diabet Med 2008;25:91-96.
16. Ng WY, Lee YS, Todd AL, Lui KF, Loke KY, Thai AC. Tyrosine phosphatase-like protein (IA-2) and glutamic acid decarboxylase (GAD65) autoantibodies: a study of Chinese patients with diabetes mellitus. Autoimmunity 2002;35:119-124.
17. Ko GT, Chan JC, Yeung VT, Chow CC, Li JK, Lau MS, et al. Antibodies to glutamic acid decarboxylase in young Chinese diabetic patients. Ann Clin Biochem 1998;35(Pt 6):761-767.
18. The DCCT Research Group. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 1987;65:30-36.
23. Welch GW, Jacobson AM, Polonsky WH. The problem areas in diabetes scale. An evaluation of its clinical utility. Diabetes Care 1997;20:760-766.
24. Li C, Barker L, Ford ES, Zhang X, Strine TW, Mokdad AH. Diabetes and anxiety in US adults: findings from the 2006 Behavioral Risk Factor Surveillance System. Diabet Med 2008;25:878-881.
25. Kampling H, Mittag O, Herpertz S, Baumeister H, Kulzer B, Petrak F. Can trajectories of glycemic control be predicted by depression, anxiety, or diabetes-related distress in a prospective cohort of adults with newly diagnosed type 1 diabetes? Results of a five-year follow-up from the German multicenter diabetes cohort study (GMDC-Study). Diabetes Res Clin Pract 2018;141:106-117.
26. Lee WR. The changing demography of diabetes mellitus in Singapore. Diabetes Res Clin Pract 2000;50 Suppl 2:S35-S39.
27. Jaacks LM, Liu W, Ji L, Mayer-Davis EJ. Type 1 diabetes stigma in China: a call to end the devaluation of individuals living with a manageable chronic disease. Diabetes Res Clin Pract 2015;107:306-307.
31. Rechenberg K, Whittemore R, Grey M. Anxiety in youth with type 1 diabetes. J Pediatr Nurs 2017;32:64-71.
37. Kleinman A. Culture and depression. N Engl J Med 2004;351:951-953.
38. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000;23:934-942.
40. de Wit M, Delemarre-van de Waal HA, Bokma JA, Haasnoot K, Houdijk MC, Gemke RJ, et al. Follow-up results on monitoring and discussing health-related quality of life in adolescent diabetes care: benefits do not sustain in routine practice. Pediatr Diabetes 2010;11:175-181.
42. Shulman R, Luo J, Shah BR. Mental health visits and low socio-economic status in adolescence are associated with complications of type 1 diabetes in early adulthood: a population-based cohort study. Diabet Med 2018;35:920-928.
43. Semenkovich K, Patel PP, Pollock AB, Beach KA, Nelson S, Masterson JJ, et al. Academic abilities and glycaemic control in children and young people with type 1 diabetes mellitus. Diabet Med 2016;33:668-673.